logo-alt.png
Global Antidepressant Market: Increased Stress Levels over the Covid-19 Outbreak - PMI
June 30, 2020 10:40 ET | PMI
Covina, CA, June 30, 2020 (GLOBE NEWSWIRE) -- The global antidepressant market accounted for US$ 13.2 billion in 2019 and is estimated to be US$ 26.1 billion by 2029 and is anticipated to register a...
Plastic Surgeon Announces 2nd Location & Cooltone® Device
October 07, 2019 13:24 ET | Stephens Plastic Surgery
BATON ROUGE, La., Oct. 07, 2019 (GLOBE NEWSWIRE) -- J. Anthony Stephens, MD is pleased to announce the Grand Opening of his second location within Skincare Aesthetics’ state-of-the-art facility in...
BioDelivery Sciences logo
BioDelivery Sciences to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019
July 30, 2019 07:45 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., July 30, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company dedicated to patients living with chronic conditions,...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Allergan plc (NYSE: AGN) on Behalf of Allergan Shareholders and Encourages Allergan Investors to Contact the Firm
June 26, 2019 16:32 ET | Bragar Eagel & Squire
NEW YORK, June 26, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Allergan plc (NYSE: AGN) on behalf of Allergan...
BioDelivery Sciences logo
BioDelivery Sciences Named to the Russell 3000® Index
June 20, 2019 08:00 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., June 20, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is set to be added to the broad-market Russell 3000® Index as well as the Russell 2000® Index...
Maxwell Aesthetics logo.jpg
Allergan Launches Dr. Jacob Unger’s Breast Reconstruction Invention Fourté for Use in 2019
June 06, 2019 13:36 ET | Maxwell Aesthetics
NASHVILLE, Tenn., June 06, 2019 (GLOBE NEWSWIRE) -- Dr. Jacob Unger is proud to announce that his invention, Fourté, officially launched at Allergan’s national sales meeting earlier this year. The...
BioDelivery Sciences logo
BioDelivery Sciences to Report Fourth Quarter and Full Year 2018 Financial Results
February 21, 2019 07:45 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., Feb. 21, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients...
BioDelivery Sciences logo
BioDelivery Announces Expanded Preferred Insurance Coverage For BELBUCA®
February 04, 2019 08:03 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., Feb. 04, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients...
Block & Leviton LLP Logo
Block & Leviton LLP Reminds Shareholders of Securities Class Action Against Allergan; Investors Are Encouraged to Contact the Firm
January 29, 2019 10:00 ET | Block & Leviton LLP
BOSTON, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, reminds investors that it has filed a securities...
Editas-Logo-Small (1).jpg
Editas Medicine Announces Publication in Nature Medicine of Data Supporting the Development of EDIT-101 to Treat Leber Congenital Amaurosis 10 (LCA10)
January 21, 2019 11:00 ET | Editas Medicine, Inc.
CAMBRIDGE, Mass., Jan. 21, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced the journal Nature Medicine published the comprehensive,...